Josep Ll. Sanfeliu

Managing Partner @ Asabys Partners | MBA, LLM, Private Equity Venture Capital in science and healthtech, Angel Investor, Musician and Pianist

📍 Greater Barcelona Metropolitan Area, Spain🔄 Updated September 2026💼 4 investments📅 17 years investing🗓 Last invested Jun 2021𝕏 @upgrade_to_unlock
VC🌍 Spain
4
Total investments
0
Early stage
1
Mid stage
0
Late stage
17y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer as an Asabys Partners investment
Jun 2021
At Koa Health, we’ve made it our mission to leverage technology and research to create simple, personal, and accessible mental health support by combining evidence, cutting-edge tech, and user-centered design. We create breakthrough interventions backed by science with one clear goal: to improve people’s mental health. Designed to help your employees find the right mental healthcare at the right time, Koa Health’s comprehensive care model, Koa Care 360 offers employees simple navigation and personalized, evidence-based care built with the world’s leading clinician-academics. Koa Health provides an integrated approach to care that delivers mental health for everyone, whether they prefer digital-first care or would benefit from clinical services delivered by a human. Available to more than 3 million users worldwide, Koa Health addresses the full continuum of mental health needs – from prevention to treatment. Backed by leading investors such as Morningside, Ancora Finance Group, Wellington Partners Life Sciences, and MTIP, Koa Health leverages deep clinical expertise, research, and technology to deliver effective and accessible care that adapts to users’ unique circumstances, leading to lasting behavior change and positive health outcomes across the full continuum of mental health. Want to learn more about life at Koa Health? Visit our website at koahealth.com Our international team of behavioral scientists, developers, designers and health innovation leaders work, learn and grow together in a collaborative and inclusive culture. Want to learn more about life at Koa Health? Visit our website at koahealth.com
Board Member (private investment)
Jan 2021
We are a Barcelona deep-tech AI startup traveling from cognition synthesis to machine intelligence. On top of our model of biological abstract cognitive computing, we are developing a novel Synthetic Cognition tech to enable the first educable and intelligent AIs. We want to lead a new era of AI and ensure it is for the best of all humankind and our well-being. We are constantly looking for the best talent for our Barcelona-based team! If you are a computer engineer or computational mathematician with AI, cognition, or neuroscience expertise, willing to solve with us the challenge of cognition and intelligence, drop us your CV at talent@avatarcognition.com
Experience · 23 entries
All (23)
Investments (4)
Founder (3)
Board (4)
2023
Board Director as an Asabys Partners investment
Jan 2023
deepull is a development-stage clinical diagnostics company focusing on direct from blood sepsis diagnostics. We are based in Barcelona, Spain.
2021
Board Observer as an Asabys Partners investment
Jun 2021
At Koa Health, we’ve made it our mission to leverage technology and research to create simple, personal, and accessible mental health support by combining evidence, cutting-edge tech, and user-centered design. We create breakthrough interventions backed by science with one clear goal: to improve people’s mental health. Designed to help your employees find the right mental healthcare at the right time, Koa Health’s comprehensive care model, Koa Care 360 offers employees simple navigation and personalized, evidence-based care built with the world’s leading clinician-academics. Koa Health provides an integrated approach to care that delivers mental health for everyone, whether they prefer digital-first care or would benefit from clinical services delivered by a human. Available to more than 3 million users worldwide, Koa Health addresses the full continuum of mental health needs – from prevention to treatment. Backed by leading investors such as Morningside, Ancora Finance Group, Wellington Partners Life Sciences, and MTIP, Koa Health leverages deep clinical expertise, research, and technology to deliver effective and accessible care that adapts to users’ unique circumstances, leading to lasting behavior change and positive health outcomes across the full continuum of mental health. Want to learn more about life at Koa Health? Visit our website at koahealth.com Our international team of behavioral scientists, developers, designers and health innovation leaders work, learn and grow together in a collaborative and inclusive culture. Want to learn more about life at Koa Health? Visit our website at koahealth.com
Board Member (private investment)
Jan 2021
We are a Barcelona deep-tech AI startup traveling from cognition synthesis to machine intelligence. On top of our model of biological abstract cognitive computing, we are developing a novel Synthetic Cognition tech to enable the first educable and intelligent AIs. We want to lead a new era of AI and ensure it is for the best of all humankind and our well-being. We are constantly looking for the best talent for our Barcelona-based team! If you are a computer engineer or computational mathematician with AI, cognition, or neuroscience expertise, willing to solve with us the challenge of cognition and intelligence, drop us your CV at talent@avatarcognition.com
2020
Board Director as an Asabys Partners investment
Oct 2020
Sidekick Health is a digital therapeutics company that helps people prevent and manage chronic diseases. Our approach combines behavioral economics, gamification, and artificial intelligence for an engaging experience that removes barriers to health behavior change and expands the possibilities of well-being. Together with our pharmaceutical and insurance partners, we design personalized lifestyle change programs that improve health outcomes and treatment adherence, create connections between patients and clinicians, and deliver data insights into some of the world's most pressing health challenges.
Board Director as an Asabys Partners investment
Aug 2020
Medasense is transforming the way PAIN is being assessed and treated worldwide. Through our breakthrough NOL® AI technology and sensing platform, we quantify pain response to optimize care and avoid overmedication. Medasense’s flagship product, PMD-200™, is used in critical care settings, where patients are unable to communicate, to visualize pain response and personalize treatment. Clinical studies have demonstrated its impact on patient safety and outcomes – including opioid sparing and lower pain scores reported by patients. PMD-200™ is distributed in Europe by Medtronic, and is also commercially available in Canada, Latin America, Israel, Australia and the United Arab Emirates. It enables connectivity with Philips and Mindray patient monitors. Along our path to improve pain care in additional settings, we are harnessing our AI capabilities with NOLedge™, an agile investigational device to lead prediction, stratification and prevention strategies that will enable better pain management and reduce healthcare expenditures.
Show all 23 entries ↓
Investment activity
2009–2021 · 4 investments
200912013120212
Recent (last 2 years)Earlier